Madrid

• Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal … Recruiting
  2024-514542-37-00 9 2020-08-13 Select advanced solid tumors and Non-Small Cell Lung Cancer with MET a
• An experimental study in adults and adolescents who underwent stem cell transplantation and developed a Graft versus Host Disease after ster … Recruiting
  2023-505737-26-00 5 2020-07-22 Steroid refractory Acute Graft versus host Disease
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 5 2020-07-20 atypical teratoid/rhabdoid tumours (ATRT)
• A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting
  2022-501050-11-01 10 2020-07-13 Acute Lymphoblastic Leukaemia
• Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced … Recruiting
  2023-509846-36-00 9 2020-05-29 Advanced Solid Tumors
• Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with … Recruiting
  2024-511523-33-00 9 2020-05-28 Fanconi anemia (subtype A)
• Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) Recruiting
  2023-506546-23-00 5 2020-05-20 Acute myeloid leukemia
• Pan tumor Roll Over Study Recruiting
  2023-506914-32-00 4 2020-05-05 Pan tumor
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to … Recruiting
  2023-509847-29-00 7 2020-04-09 Advanced solid tumors
• Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting
  2023-508956-20-00 5 2020-03-12 Hidradenitis suppurativa
• A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-00 … Recruiting
  2024-512606-25-00 7 2019-12-20 Advanced Solid Tumors
• A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck. Recruiting
  2023-508561-33-00 7 2019-12-12 Newly diagnosed, stage III or IV amenable to surgery, HPV negative, sq
• SIOP RANDOMET 2017 Recruiting
  2023-508926-91-00 5 2019-12-05 Stage IV childhood renal tumour with pulmonary +/- non-pulmonary metas
• A study evaluating the safety and efficacy of ponatinib for the treatment of recurrent or refractory leukemias or solid tumors in children Recruiting
  2023-509699-41-00 9 2019-11-22 Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors
• A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA Recruiting
  2023-507883-38-00 5 2019-11-18 Systemic Juvenile Idiopathic Arthritis
• A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Ante … Recruiting
  2023-505811-18-00 5 2019-11-11 Uveitis
• A study to evaluate efficacy and safety of perampanel when administered together with other current antiepileptic medications in children wi … Recruiting
  2023-507794-17-00 4 2019-11-11 Childhood Epilepsy
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or … Recruiting
  2023-507149-27-00 5 2019-11-04 Chemotherapy-induced Thrombocytopenia in Adult subjects with Non-small
• Long-term efficacy, safety and tolerability of LNP023 in C3G or IC-MPGN Recruiting
  2023-509343-27-00 11 2019-10-28 C3 Glomerulopathy or idiopathic immune-complex membranoproliferative g
• Phase 3, Open-label Apremilast Pediatric Long-term Extension Study in Children with Oral Ulcers Associated With Behçet’s Disease or Juvenile … Recruiting
  2023-503433-21-00 5 2019-10-03 Behçet’s disease is a chronic, relapsing, multisystem inflammatory dis
• Study of two doses of crizanlizumab versus placebo in adolescent and adult sickle cell disease patients Recruiting
  2023-508689-14-00 5 2019-09-16 Sickle cell disease
• An open-label study to assess safety and efficacy of SZC in paediatric patients with hyperkalaemia Recruiting
  2023-508455-38-00 5 2019-09-12 Hyperkalaemia
• A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JUVE-X) Recruiting
  2023-506131-15-00 5 2019-09-10 Juvenile Idiopathic Arthritis
• Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Recruiting
  2023-509179-18-00 1 2019-08-13 Castration Resistant Prostate Cancer (CRPC)

Showing 1,609–1,632 of 3,550 trials